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A B S T R A C T   
Introduction: Endovascular aneurysm sealing (EVAS) with the Nellix system was introduced to reduce endovas-
cular aneurysm repair (EVAR) perioperative complications, especially endoleaks. Herein we report a case of 
successful type 1A endoleak managed with detachable coils embolization after EVAS. 
Presentation of case: A 77-year-old male was referred for abdominal pain. The angio-CT scan confirmed the 
previous EVAS procedure and showed a type Is2 endoleak below the right renal artery resulting in a 2.5 cm aortic 
blister with contrast medium filling the space between the aortic wall and the endobags. The patient was 
considered unfit for conventional open surgery and an endovascular approach with coil embolization Concerto 
Helix Detachable Coil System was chosen under local anesthesia. After intervention, a complete abdominal pain 
regression was registered. The 12- month CT follow-up showed endoleak sealing and Nellix system stability. 
Discussion: EVAS has been associated to a high endoleaks and complications incidence when compared to EVAR. 
The EVAS different device concept led to a different endoleak classification and management. Endoleak man-
agement main options include the Nellix system explantation or the Nellix in Nellix application, however these 
are nearly always not applicable, respectively, due to the high surgical risk condition and the Nellix system 
availability, especially in emergent setting. Despite the use of coil embolization is controversial, this tool is off- 
the-shelf and leads to a disease resolution in most of patients without other surgical options. 
Conclusion: Proximal type Is2 embolization after EVAS is feasible with limited invasiveness.   
1. Introduction 
Endovascular repair of aortic aneurysm (EVAR) is a continuously 
increasing procedure as it represents the gold standard in abdominal 
aortic aneurysm (AAA) treatment. Endovascular aneurysm sealing 
(EVAS), with the Nellix system (Endologix Inc., Irvine, CA, US) has been 
introduced with the aim to reduce EVAR perioperative complications, 
especially endoleaks by filling endobags in order to seal the aneurysm 
[1]. Despite encouraging short outcomes, mid- and longer-term results 
have shown a significant higher incidence of EVAS related complica-
tions, and in 2019 the Nellix system (Endologix Inc.) has been with-
drawn from the marked [2]. Herein we report a case of type 1A endoleak 
after EVAS managed with detachable coils embolization. 
This work has been written in accordance with the SCARE criteria 
[3]. 
2. Case report 
A 77-year-old male with hypertension, diabetes mellitus, reduced 
cardiac output (35% cardiac ejection fraction), moderate renal failure 
was referred for abdominal pain. At admission, his physical examination 
revealed regular heart rate of 80 beats/min, blood pressure of 140/70 
mmHg and temperature of 36.8 ◦C. At history, he referred a previous 
EVAS procedure using the Nellix system (Endologix Inc.) carried at 
another hospital 17 months before. 
The angio-CT scan confirmed the previous EVAS procedure and 
showed a type Is2 endoleak below the right renal artery resulting in a 
2.5 cm aortic blister and contrast medium filling the space between the 
aortic wall and the endobags (Fig. 1). In addition, a 26 mm maximal 
diameter left internal iliac artery and an occluded left renal artery were 
evident (Fig. 2). 
The patient was considered unfit for conventional open surgery and 
an endovascular approach was chosen. Different endovascular options 
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Fig. 1. Preoperative CT Angiography showing endoleak in traversal plane (A) and coronal plane (B).  
E. Dinoto et al.                                                                                                                                                                                                                                  
International Journal of Surgery Case Reports 83 (2021) 106024
3
have been employed to address such complication, but considering the 
narrow type 1A endoleak entry a coil embolization was chosen. 
Under local anesthesia, a right radial access was gained and a 
6Fx90cm Destination sheath (Terumo Europe, Leuven, Belgium) placed. 
The sheath tip was placed a few centimeters below the top of the 
endograft. Anteroposterior and lateral aortograms were performed using 
a flush catheter paced above the proximal end of the endografts to 
identify the type 1A endoleak origin (Fig. 3). 
The type 1A endoleak entrance was catheterized using a 5F Ber 
catheter (Cordis, Miami, FL) and a 0.018 microcatheter (Rebar18; 
Medtronic, Inc., Minneapolis, MN, US) was advanced coaxially under 
fluoroscopic visualization into the type 1A endoleak cavity. Subse-
quently through the 0.018 microcatheter, two (16 mm 40 cm first and 
14 mm 30 cm second) Concerto Helix Detachable Coil System (Med-
tronic, Inc., Minneapolis, MN, US) were released inside the aneurysm sac 
to fill the type 1A endoleak (Fig. 4). The control angiography confirmed 
the type 1A endoleak sealing after coil embolization (Fig. 5). At 6 h from 
the intervention the patient was asymptomatic for abdominal pain and 
stable laboratory tests; the patient was discharged on the 3rd post-
operative day. 
The 12 months CT-angiography showed complete type 1A endoleak 
sealing and Nellix system (Endologix Inc.) stability (Fig. 6). 
3. Discussion 
Endoleaks are EVAR-related complications occurring immediately or 
during the follow-up [4]. One of the potential advantages introduced 
with EVAS was a reduced endoleak occurrence [5]. 
Despite this assumption, when compared to standard EVAR, EVAS 
was associated with a higher endoleak occurrence and device failure up 
43.5% at long-term [2]. Actually, all patients treated with Nellix system 
(Endologix Inc.) are at risk of AAA growth and stent migration 
Fig. 2. Preoperative CT Angiography showing left iliac aneurysm.  
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Fig. 3. Intraoperative Angiography showing endoleak.  
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independently forms instruction for use adherence [6]. 
A different concern regarding type IA endoleaks was reported after 
EVAS due to a different aneurysm exclusion. The different EVAS im-
plantation rationale required a different endoleak classification as pro-
posed by van den Ham et al. with the aim to anticipate progression and 
the eventual treatment. Type Is1 endoleak was defined as contrast pas-
sage between the endobag and the wall of the proximal neck, not 
reaching the aneurysm sac itself; Type Is2 endoleak as contrast passage 
between the endobag and aneurysmal wall or thrombus inside the 
aneurysm sac; Type Is3 as contrast or fresh thrombus between the 
endobags inside the aneurysm sac; and Type Is4 endoleak as aneurysm 
sac pressurization without an evident contrast presence into the 
excluded aneurysm [7]. 
In addition, the Nellix endobags filled with the polymer present 
different density at different interval time after implantation, making 
endoleak diagnosis complex especially early after implantation [8]. 
Type I endoleak occurrence after EVAR is a clear indication for 
reintervention [9]. Different approaches have been proposed including 
the Nellix system (Endologix Inc.) surgical explanation; Nellix in Nellix 
application (NINA); proximal embolization. Singh et al. reported a large 
experience in EVAS failure management with a clear indication to sur-
gical explanation in fit patients. The same authors argued that NINA 
could not represent an option due to the resilience from the manufacture 
to provide graft removed from the market [2]. However, it can be argued 
that all the worldwide implanted Nellix system (Endologix Inc.) would 
require a reintervention for device failure, and most of them will be unfit 
for conventional surgery, as reported in our case. 
In these circumstances, for asymptomatic patients observation could 
be an option; for symptomatic and/or ruptured cases alternative thera-
peutic options has to be considered. 
Proximal embolization has been associated with high failure inci-
dence and inefficiency regarding Nellix system (Endologix Inc.) migra-
tion [2]. In this single case experience the 6-months CT angiography 
showed complete AAA exclusion and Nellix system (Endologix Inc.) 
stability. 
4. Conclusion 
Late failures after Nellix system (Endologix Inc.) are supposed to be 
observed due to graft failure. Patients requiring emergent treatment for 
type I endoleak should be managed by surgical Nellix system (Endologix 
Inc.) explanation. NINA in unfit patients for open surgery patients is 
excluded due to manufacture restriction with the Nellix system (Endo-
logix Inc.). Despite concern in term of durability, proximal embolization 
is feasible and this tool should be taken in account especially in emer-
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Fig. 5. Control angiography showing exclusion of the type 1A endoleak after coil embolization.  
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Fig. 6. Preoperative CT Angiography with endoleak (A) and 6-months postoperative CT Angiography (B).  
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